210 related articles for article (PubMed ID: 304199)
1. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
Marroum MC; Huvos AG; Rosen G
Oncology; 1977; 34(6):273-80. PubMed ID: 304199
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
[TBL] [Abstract][Full Text] [Related]
3. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.
Huvos AG; Rosen G; Marcove RC
Arch Pathol Lab Med; 1977 Jan; 101(1):14-8. PubMed ID: 299812
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
[TBL] [Abstract][Full Text] [Related]
6. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
[No Abstract] [Full Text] [Related]
7. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
Beattie EJ; Martini N; Rosen G
Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
[TBL] [Abstract][Full Text] [Related]
8. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
9. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
11. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
[No Abstract] [Full Text] [Related]
13. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
[TBL] [Abstract][Full Text] [Related]
14. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma.
Rosen G; Tefft M; Martinez A; Cham W; Murphy ML
Cancer; 1975 Mar; 35(3):622-30. PubMed ID: 1078640
[TBL] [Abstract][Full Text] [Related]
16. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity.
Pratt C; Shanks E; Hustu O; Rivera G; Smith J; Kumar AP
Cancer; 1977 Jan; 39(1):51-7. PubMed ID: 299829
[TBL] [Abstract][Full Text] [Related]
18. High-dose methotrexate and adriamycin in osteogenic sarcoma: the children's hospital of Philadelphia study.
Lange B; Kramer S; Gregg JR; Toledano S; Wimmer R; Evans AE
Am J Clin Oncol; 1982 Feb; 5(1):3-8. PubMed ID: 6979238
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of malignant fibrous histiocytoma of bone. A report of five cases.
Urban C; Rosen G; Huvos AG; Caparros B; Cacavio A; Nirenberg A
Cancer; 1983 Mar; 51(5):795-802. PubMed ID: 6295615
[TBL] [Abstract][Full Text] [Related]
20. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
Jaffe N
Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
